Cite
MLA Citation
Balazs Halmos et al.. “Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo).” Lung cancer, vol. 127, 2019, pp. 103–111. http://access.bl.uk/ark:/81055/vdc_100076783716.0x000031